Last reviewed · How we verify
NCT07030218: FLAG-VS
A Warning Red Flag Classification System to Predict Risk of Vasovagal Syncope During Office Hysteroscopy
trial testing Office hysteroscopy in Vasovagal Syncope (VVS) in 46 participants. Enrolling by invitation.
10 October 2025
Quick facts
| Lead sponsor | Tanvir Hospital |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 46 |
| Start date | 20 June 2025 |
| Primary completion | 10 October 2025 |
| Estimated completion | 10 October 2025 |
| Sites | 1 location across India |
Drugs / interventions tested
- Office hysteroscopy
Conditions studied
- Vasovagal Syncope (VVS) — all drugs for Vasovagal Syncope (VVS) →
Sponsor
Tanvir Hospital
Who can join
18 and older, female only, with Vasovagal Syncope (VVS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this pilot cross sectional study is to identify participants at risk of vasovagal reaction/syncope(VVR/VVS) during office hysteroscopy. A predictive red flag classification system is being studied to improve procedural safety during office hysteroscopy. Researchers will perform office hysteroscopy as per the standard protocol by vaginoscopic technique. A nurse positioned at the head side of the participant will record signs and symptoms of VVR/VVS. The participant will be asked of the severity of the pain experienced during office hysteroscopy in relation to their menstrual cycle. The procedure will be discontinued at any point the participant wishes to stop.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07030218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Office hysteroscopy
Trials testing the same drug.
- NCT06550544 — Hysteroscopic Guided Versus Ultrasound Guided Extraction of Retained IUD · NA · not yet recruiting
- NCT04415489 — SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF · NA · completed
- NCT03265301 — Hysteroscopic Surgery in Treatment of Intrauterine Abnormalities · NA · withdrawn
- NCT02746588 — Description of the Uterine Cavity in Patients With Recurrent Miscarriages · completed
Other recruiting trials for Vasovagal Syncope (VVS)
Currently open trials in the same condition.
- NCT07459478 — Assesment of the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial · NA · recruiting
- NCT05755737 — A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Tr · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07030218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanvir Hospital
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07030218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing